Two Key Studies Support Role of CancerTYPE ID® Molecular Cancer …
Individualizing cancer care and improving patients’ lives by translating scientific discovery into novel molecular tests.
In ER+ early-stage breast cancer
The only robust, validated tool to help with clinical decision-making for extended endocrine treatment
Actionable genomic information for accurate diagnosis and treatment of metastatic cancerCancerTYPE ID and CancerTREATMENT NGS+